Cargando…
SARS-CoV-2 Detection in Gingival Crevicular Fluid
Understanding the pathophysiology of the coronavirus disease 2019 (COVID-19) infection remains a significant challenge of our times. The gingival crevicular fluid being representative of systemic status and having a proven track record of detecting viruses and biomarkers forms a logical basis for ev...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642823/ https://www.ncbi.nlm.nih.gov/pubmed/33138663 http://dx.doi.org/10.1177/0022034520970536 |
_version_ | 1783606159334178816 |
---|---|
author | Gupta, S. Mohindra, R. Chauhan, P.K. Singla, V. Goyal, K. Sahni, V. Gaur, R. Verma, D.K. Ghosh, A. Soni, R.K. Suri, V. Bhalla, A. Singh, M.P. |
author_facet | Gupta, S. Mohindra, R. Chauhan, P.K. Singla, V. Goyal, K. Sahni, V. Gaur, R. Verma, D.K. Ghosh, A. Soni, R.K. Suri, V. Bhalla, A. Singh, M.P. |
author_sort | Gupta, S. |
collection | PubMed |
description | Understanding the pathophysiology of the coronavirus disease 2019 (COVID-19) infection remains a significant challenge of our times. The gingival crevicular fluid being representative of systemic status and having a proven track record of detecting viruses and biomarkers forms a logical basis for evaluating the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The study aimed to assess gingival crevicular fluid (GCF) for evidence of SARS-CoV-2 in 33 patients who were deemed to be COVID-19 positive upon nasopharyngeal sampling. An attempt was also made to comparatively evaluate it with saliva in terms of its sensitivity, as a diagnostic fluid for SARS-CoV-2. GCF and saliva samples were collected from 33 COVID-19–confirmed patients. Total RNA was extracted using NucliSENS easyMAG (bioMérieux) and eluted in the elution buffer. Envelope gene (E gene) of SARS-CoV-2 and human RNase P gene as internal control were detected in GCF samples by using the TRUPCR SARS-CoV-2 RT qPCR kit V-2.0 (I) in an Applied Biosystems 7500 real-time machine. A significant majority of both asymptomatic and mildly symptomatic patients exhibited the presence of the novel coronavirus in their GCF samples. Considering the presence of SARS-CoV-2 RNA in the nasopharyngeal swab sampling as gold standard, the sensitivity of GCF and saliva, respectively, was 63.64% (confidence interval [CI], 45.1% to 79.60%) and 64.52% (CI, 45.37% to 80.77%). GCF was found to be comparable to saliva in terms of its sensitivity to detect SARS-CoV-2. Saliva samples tested positive in 3 of the 12 patients whose GCF tested negative, and likewise GCF tested positive for 2 of the 11 patients whose saliva tested negative on real-time reverse transcription polymerase chain reaction. The results establish GCF as a possible mode of transmission of SARS-CoV-2, which is the first such report in the literature, and also provide the first quantifiable evidence pointing toward a link between the COVID-19 infection and oral health. |
format | Online Article Text |
id | pubmed-7642823 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-76428232020-11-05 SARS-CoV-2 Detection in Gingival Crevicular Fluid Gupta, S. Mohindra, R. Chauhan, P.K. Singla, V. Goyal, K. Sahni, V. Gaur, R. Verma, D.K. Ghosh, A. Soni, R.K. Suri, V. Bhalla, A. Singh, M.P. J Dent Res Research Reports Understanding the pathophysiology of the coronavirus disease 2019 (COVID-19) infection remains a significant challenge of our times. The gingival crevicular fluid being representative of systemic status and having a proven track record of detecting viruses and biomarkers forms a logical basis for evaluating the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The study aimed to assess gingival crevicular fluid (GCF) for evidence of SARS-CoV-2 in 33 patients who were deemed to be COVID-19 positive upon nasopharyngeal sampling. An attempt was also made to comparatively evaluate it with saliva in terms of its sensitivity, as a diagnostic fluid for SARS-CoV-2. GCF and saliva samples were collected from 33 COVID-19–confirmed patients. Total RNA was extracted using NucliSENS easyMAG (bioMérieux) and eluted in the elution buffer. Envelope gene (E gene) of SARS-CoV-2 and human RNase P gene as internal control were detected in GCF samples by using the TRUPCR SARS-CoV-2 RT qPCR kit V-2.0 (I) in an Applied Biosystems 7500 real-time machine. A significant majority of both asymptomatic and mildly symptomatic patients exhibited the presence of the novel coronavirus in their GCF samples. Considering the presence of SARS-CoV-2 RNA in the nasopharyngeal swab sampling as gold standard, the sensitivity of GCF and saliva, respectively, was 63.64% (confidence interval [CI], 45.1% to 79.60%) and 64.52% (CI, 45.37% to 80.77%). GCF was found to be comparable to saliva in terms of its sensitivity to detect SARS-CoV-2. Saliva samples tested positive in 3 of the 12 patients whose GCF tested negative, and likewise GCF tested positive for 2 of the 11 patients whose saliva tested negative on real-time reverse transcription polymerase chain reaction. The results establish GCF as a possible mode of transmission of SARS-CoV-2, which is the first such report in the literature, and also provide the first quantifiable evidence pointing toward a link between the COVID-19 infection and oral health. SAGE Publications 2020-11-02 2021-02 /pmc/articles/PMC7642823/ /pubmed/33138663 http://dx.doi.org/10.1177/0022034520970536 Text en © International & American Associations for Dental Research 2020 https://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Research Reports Gupta, S. Mohindra, R. Chauhan, P.K. Singla, V. Goyal, K. Sahni, V. Gaur, R. Verma, D.K. Ghosh, A. Soni, R.K. Suri, V. Bhalla, A. Singh, M.P. SARS-CoV-2 Detection in Gingival Crevicular Fluid |
title | SARS-CoV-2 Detection in Gingival Crevicular Fluid |
title_full | SARS-CoV-2 Detection in Gingival Crevicular Fluid |
title_fullStr | SARS-CoV-2 Detection in Gingival Crevicular Fluid |
title_full_unstemmed | SARS-CoV-2 Detection in Gingival Crevicular Fluid |
title_short | SARS-CoV-2 Detection in Gingival Crevicular Fluid |
title_sort | sars-cov-2 detection in gingival crevicular fluid |
topic | Research Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642823/ https://www.ncbi.nlm.nih.gov/pubmed/33138663 http://dx.doi.org/10.1177/0022034520970536 |
work_keys_str_mv | AT guptas sarscov2detectioningingivalcrevicularfluid AT mohindrar sarscov2detectioningingivalcrevicularfluid AT chauhanpk sarscov2detectioningingivalcrevicularfluid AT singlav sarscov2detectioningingivalcrevicularfluid AT goyalk sarscov2detectioningingivalcrevicularfluid AT sahniv sarscov2detectioningingivalcrevicularfluid AT gaurr sarscov2detectioningingivalcrevicularfluid AT vermadk sarscov2detectioningingivalcrevicularfluid AT ghosha sarscov2detectioningingivalcrevicularfluid AT sonirk sarscov2detectioningingivalcrevicularfluid AT suriv sarscov2detectioningingivalcrevicularfluid AT bhallaa sarscov2detectioningingivalcrevicularfluid AT singhmp sarscov2detectioningingivalcrevicularfluid |